Metformin × adverse events & safety

SynthesisThe oncologist2012

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis.

Davide Soranna et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation, not cause

Went with lower adverse events & safety

−39%−46% to −30%

Bigger than 7 in 10 for adverse events & safety

As reported

RR 0.61, 95% CI 0.54–0.70

One number in the abstract

the abstract, start to end

decreased RR of all cancers (summary RR 0.61, 95% confidence interval [CI]

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
RR 0.610.54–0.70
MetforminAdverse events & safety
1 / 3

128 papers cite itlatest 60 shown

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 22643536